{"url":"https://lda.senate.gov/api/v1/filings/c3285776-2edb-4bcf-9039-e2d7856535d3/","filing_uuid":"c3285776-2edb-4bcf-9039-e2d7856535d3","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2011,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/c3285776-2edb-4bcf-9039-e2d7856535d3/print/","filing_document_content_type":"text/html","income":"105000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Sara Zborovski","dt_posted":"2011-04-20T14:58:44.237000-04:00","termination_date":null,"registrant_country":"Canada","registrant_ppb_country":null,"registrant_address_1":"THE FLATIRON BUILDING, FIRST FLOOR","registrant_address_2":"49 WELLINGTON STREET EAST","registrant_different_address":false,"registrant_city":"TORONTO","registrant_state":"ON","registrant_zip":null,"registrant":{"id":67876,"url":"https://lda.senate.gov/api/v1/registrants/67876/","house_registrant_id":35694,"name":"GILBERT'S LLP","description":null,"address_1":"THE FLATIRON BUILDING, FIRST FLOOR","address_2":"49 WELLINGTON STREET EAST","address_3":"TORONTO","address_4":"ON M5K1K2","city":"TORONTO","state":"ON","state_display":"ON","zip":"M5E 1-C9","country":"CA","country_display":"Canada","ppb_country":"CA","ppb_country_display":"Canada","contact_name":"TIM GILBERT","contact_telephone":"+1 416-703-1100","dt_updated":"2022-04-06T16:07:17.759172-04:00"},"client":{"id":163997,"url":"https://lda.senate.gov/api/v1/clients/163997/","client_id":36,"name":"MYLAN LABORATORIES INC","general_description":null,"client_government_entity":false,"client_self_select":null,"state":"PA","state_display":"Pennsylvania","country":"US","country_display":"United States of America","ppb_state":null,"ppb_state_display":null,"ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-14"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Reform to legislation and regulations affecting pharmaceutical approvals and related patent issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":48056,"prefix":"mr","prefix_display":"MR.","first_name":"TIM","nickname":null,"middle_name":null,"last_name":"GILBERT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":49516,"prefix":"mr","prefix_display":"MR.","first_name":"NATHANIEL","nickname":null,"middle_name":"BRANDON","last_name":"LIPKUS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}